# Ari-Med Pharmaceuticals, Tempe, AZ – FDA Inspections

Source: https://www.keypedia.com/companies/ari-med-pharmaceuticals/3c747ce9-28ae-4c58-9b29-bf861e144db3

> Inspection records and compliance data for Ari-Med Pharmaceuticals in Tempe, Arizona. 6 FDA inspections on record, last inspected October 24, 2019.

---

## Details

- Name: Ari-Med Pharmaceuticals
- FEI Number: 2027206
- Address Line 1: 1615 W University Dr Ste 135
- City: Tempe
- State: Arizona
- Zip Code: 85281
- Country Name: United States
- Address: 1615 W University Dr Ste 135, Tempe, Arizona 85281, United States
- Country: United States

## Related Documents

- FDA Inspection 1111694 - Ari-Med Pharmaceuticals - 2019-10-24 — classification: No Action Indicated (NAI), source: FDA, date: October 24, 2019
- FDA Inspection 1075268 - Ari-Med Pharmaceuticals - 2018-11-15 — classification: No Action Indicated (NAI), source: FDA, date: November 15, 2018
- FDA Inspection 1075268 - Ari-Med Pharmaceuticals - 2018-11-15 — classification: No Action Indicated (NAI), source: FDA, date: November 15, 2018
- [FDA Inspection 988721 - Ari-Med Pharmaceuticals - 2016-08-17](https://www.keypedia.com/records/fda_inspections/ari-med-pharmaceuticals/12c59451-878d-4d2f-88d2-4d82cf22b8ca) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 17, 2016
- [FDA Inspection 881778 - Ari-Med Pharmaceuticals - 2014-06-02](https://www.keypedia.com/records/fda_inspections/ari-med-pharmaceuticals/f4f717f8-3f47-4899-8c21-daa92da68aea) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 2, 2014
- FDA Inspection 881778 - Ari-Med Pharmaceuticals - 2014-06-02 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 2, 2014
- FDA Inspection 726129 - Ari-Med Pharmaceuticals - 2011-05-23 — classification: No Action Indicated (NAI), source: FDA, date: May 23, 2011
- FDA Inspection 726129 - Ari-Med Pharmaceuticals - 2011-05-23 — classification: No Action Indicated (NAI), source: FDA, date: May 23, 2011
- FDA Inspection 648012 - Ari-Med Pharmaceuticals - 2010-02-22 — classification: No Action Indicated (NAI), source: FDA, date: February 22, 2010

## Related Companies

- [NPS Holdings LLC](https://www.keypedia.com/companies/nps-holdings-llc/9042e4a6-ff65-422e-aa94-0dd581a9660d)
- [Alliance Analytical Services](https://www.keypedia.com/companies/alliance-analytical-services/85487824-d406-4b1d-9738-4d6f85483ee4)
- [Sichuan Long March Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/sichuan-long-march-pharmaceutical-co-ltd/b4406a2f-721d-4f9a-b078-3d298a6d039f)
- [BASF Corporation](https://www.keypedia.com/companies/basf-corporation/033efedd-a150-4d10-a795-c49c43bcb848)
- [Cephazone Pharma, LLC](https://www.keypedia.com/companies/cephazone-pharma-llc/45f405eb-c2a2-4690-8798-cac1d3948419)
- [Wintec Pharmaceutical Inc](https://www.keypedia.com/companies/wintec-pharmaceutical-inc/2ca26550-0084-48a9-b5bb-4000da4ab157)
- [Healing Tree Products, Inc.](https://www.keypedia.com/companies/healing-tree-products-inc/6147df77-356b-46fa-8a43-3e13ce44553f)
- [Vermont's Original, LLC](https://www.keypedia.com/companies/vermonts-original-llc/737b9a89-1270-40aa-8f9e-5b534afbad6f)
- [North China Pharmaceutical Group Hualuan Co., Ltd](https://www.keypedia.com/companies/north-china-pharmaceutical-group-hualuan-co-ltd/3f6c6731-a616-4e5d-b2eb-10b0b1ca492c)
- [Yangzhou Lianao Biopharmaceutical Co., Ltd.](https://www.keypedia.com/companies/yangzhou-lianao-biopharmaceutical-co-ltd/faa34e29-5a90-4b47-9408-36e524248c4f)